These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Kiepiela P; Leslie AJ; Honeyborne I; Ramduth D; Thobakgale C; Chetty S; Rathnavalu P; Moore C; Pfafferott KJ; Hilton L; Zimbwa P; Moore S; Allen T; Brander C; Addo MM; Altfeld M; James I; Mallal S; Bunce M; Barber LD; Szinger J; Day C; Klenerman P; Mullins J; Korber B; Coovadia HM; Walker BD; Goulder PJ Nature; 2004 Dec; 432(7018):769-75. PubMed ID: 15592417 [TBL] [Abstract][Full Text] [Related]
5. New research in HIV immunity points way for vaccine. Rees J Expert Rev Clin Immunol; 2013 May; 9(5):403. PubMed ID: 23772447 [No Abstract] [Full Text] [Related]
6. Vaccine-induced CD8+ T lymphocytes of rhesus monkeys recognize variant forms of an HIV epitope but do not mediate optimal functional activity. Hulot SL; Cale EM; Korber BT; Letvin NL J Immunol; 2011 May; 186(10):5663-74. PubMed ID: 21490161 [TBL] [Abstract][Full Text] [Related]
7. T cells versus HIV-1: fighting exhaustion as well as escape. Robinson HL Nat Immunol; 2003 Jan; 4(1):12-3. PubMed ID: 12496971 [No Abstract] [Full Text] [Related]
9. Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individuals. Thorn M; Tang S; Therrien D; Kløverpris H; Vinner L; Kronborg G; Gerstoft J; Corbet S; Fomsgaard A APMIS; 2007 Jun; 115(6):757-68. PubMed ID: 17550385 [TBL] [Abstract][Full Text] [Related]
10. Priming of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cell responses by dendritic cells loaded with HIV-1 proteins. Huang XL; Fan Z; Zheng L; Borowski L; Li H; Thomas EK; Hildebrand WH; Zhao XQ; Rinaldo CR J Infect Dis; 2003 Jan; 187(2):315-9. PubMed ID: 12552458 [TBL] [Abstract][Full Text] [Related]
11. MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays. Kutscher S; Allgayer S; Dembek CJ; Bogner JR; Protzer U; Goebel FD; Erfle V; Cosma A Gene Ther; 2010 Nov; 17(11):1372-83. PubMed ID: 20535218 [TBL] [Abstract][Full Text] [Related]
12. Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity. Hoof I; Pérez CL; Buggert M; Gustafsson RK; Nielsen M; Lund O; Karlsson AC J Immunol; 2010 May; 184(9):5383-91. PubMed ID: 20363973 [TBL] [Abstract][Full Text] [Related]
13. New research in HIV immunity points way for vaccine. Rees J Immunotherapy; 2013 May; 5(5):445-6. PubMed ID: 23638739 [No Abstract] [Full Text] [Related]
14. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection. Borghan MA; Oka S; Takiguchi M Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326 [TBL] [Abstract][Full Text] [Related]
15. Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity. Russell ND; Hudgens MG; Ha R; Havenar-Daughton C; McElrath MJ J Infect Dis; 2003 Jan; 187(2):226-42. PubMed ID: 12552447 [TBL] [Abstract][Full Text] [Related]
16. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression. Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945 [TBL] [Abstract][Full Text] [Related]
17. A nonprogressive clinical course in HIV-infected individuals expressing human leukocyte antigen B57/5801 is associated with preserved CD8+ T lymphocyte responsiveness to the HW9 epitope in Nef. Navis M; Schellens IM; van Swieten P; Borghans JA; Miedema F; Kootstra NA; van Baarle D; Schuitemaker H J Infect Dis; 2008 Mar; 197(6):871-9. PubMed ID: 18279072 [TBL] [Abstract][Full Text] [Related]
18. Patient-specific cytotoxic T-lymphocyte cross-recognition of naturally occurring variants of a human immunodeficiency virus type 1 (HIV-1) p24gag epitope by HIV-1-infected children. Buseyne F; Chaix ML; Rouzioux C; Blanche S; Rivière Y J Virol; 2001 May; 75(10):4941-6. PubMed ID: 11312369 [TBL] [Abstract][Full Text] [Related]
19. In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice. Marsac D; Puaux AL; Rivière Y; Michel ML Immunobiology; 2005; 210(5):305-19. PubMed ID: 16164038 [TBL] [Abstract][Full Text] [Related]